Vertical Ear Canal Ablation

Vertical ear canal ablation (VECA) is a surgical procedure that involves the complete excision of the vertical portion of the external ear canal, preserving the horizontal canal and tympanic membrane. This procedure is indicated for chronic, irreversible diseases of the vertical canal, such as severe otitis externa, neoplasia, trauma, or stricture, where medical management has failed and the horizontal canal remains healthy. The surgery aims to remove diseased tissue, establish drainage, and alleviate pain while preserving hearing and vestibular function. Anatomically, the vertical canal extends from the external acoustic meatus (ear opening) to the junction with the horizontal canal, which then leads to the tympanic membrane. The procedure is performed via a lateral approach, with careful dissection to avoid the facial nerve, auricular vessels, and parotid gland. VECA is distinguished from total ear canal ablation (TECA) by the preservation of the horizontal canal and tympanic membrane, which maintains a functional ear canal and reduces the risk of postoperative vestibular signs.

The primary indications for vertical ear canal ablation include chronic otitis externa that is unresponsive to medical therapy, particularly when the disease is confined to the vertical canal. Underlying causes include bacterial and fungal infections (e.g., Pseudomonas aeruginosa, Malassezia pachydermatis), parasitic infestations (Otodectes cynotis), foreign bodies, and allergic dermatitis (atopy, food allergy). Neoplasia of the vertical canal, such as ceruminous gland adenoma, adenocarcinoma, squamous cell carcinoma, and fibrosarcoma, may also necessitate VECA. Traumatic injuries, including lacerations, avulsions, and fractures of the auricular cartilage, can lead to stenosis or deformity requiring surgical resection. Iatrogenic causes, such as previous ear surgery or improper ear cleaning techniques, may result in stricture or chronic inflammation. Congenital abnormalities, such as stenotic ear canals, are less common but may be treated with VECA in select cases. The underlying pathophysiology involves chronic inflammation leading to hyperplasia, fibrosis, and mineralization of the auricular cartilage, resulting in irreversible canal obstruction and infection.

Vertical ear canal ablation is most commonly performed in dogs, with a higher incidence in breeds predisposed to otitis externa, such as Cocker Spaniels, Labrador Retrievers, Golden Retrievers, German Shepherds, and Poodles. These breeds often have pendulous ears, excessive hair in the ear canal, or conformational abnormalities that predispose to moisture retention and infection. Cats are less commonly affected, but brachycephalic breeds like Persians may be at increased risk. The condition is typically seen in middle-aged to older animals, with a median age of 6-8 years, reflecting the chronic nature of the underlying disease. There is no significant sex predilection. Working dogs, such as hunting and field trial dogs, may be at increased risk due to exposure to water, debris, and trauma. The incidence of VECA is relatively low compared to TECA, as many cases of chronic otitis externa progress to involve the horizontal canal, necessitating total ablation. However, VECA is a valuable option for cases with isolated vertical canal disease, preserving hearing and reducing surgical morbidity.

The pathophysiology of diseases leading to vertical ear canal ablation begins with an inciting cause, such as infection, allergy, or trauma, that triggers an inflammatory response in the epithelial lining of the vertical canal. Acute inflammation is characterized by vasodilation, edema, and infiltration of neutrophils and macrophages. If the inciting cause persists, chronic inflammation ensues, leading to hyperplasia of the epithelium, proliferation of sebaceous and ceruminous glands, and fibrosis of the submucosa. Over time, the auricular cartilage undergoes degeneration, mineralization, and ossification, resulting in a rigid, stenotic canal. The accumulation of debris, exudate, and cerumen provides a favorable environment for bacterial and fungal overgrowth, perpetuating the cycle. In neoplastic conditions, uncontrolled cellular proliferation leads to mass formation, which can obstruct the canal and invade surrounding tissues. The vertical canal's anatomical location, with its narrow lumen and dependent position, predisposes to fluid accumulation and infection. Surgical ablation removes the diseased tissue, eliminates the nidus of infection, and provides a patent opening for drainage, thereby resolving the chronic inflammatory process.

Intrinsic predisposing factors include breed-related conformational traits such as pendulous pinnae, stenotic ear canals, and excessive hair growth within the canal, which impair ventilation and promote moisture retention. Genetic predisposition to allergic skin disease (atopy, food allergy) and seborrheic disorders can lead to chronic otitis externa. Endocrine disorders, such as hypothyroidism and sex hormone imbalances, may alter the cutaneous barrier and increase susceptibility to infection. Age-related changes, including decreased immune function and glandular atrophy, can contribute to chronicity. Extrinsic factors include environmental allergens (pollens, dust mites), dietary allergens, and irritants such as excessive moisture from swimming or bathing. Inappropriate ear cleaning techniques, such as using cotton swabs or harsh chemicals, can traumatize the canal and exacerbate inflammation. Previous medical management with topical or systemic antibiotics may lead to resistant infections. Prior ear surgery, such as lateral wall resection, can alter the anatomy and predispose to stenosis. Trauma from foreign bodies, bites, or blunt force can cause cartilage damage and scarring.

Clinical signs of vertical ear canal disease include head shaking, ear scratching, rubbing the ear on the ground or furniture, and pain on palpation of the ear base. There is often a malodorous discharge from the ear, which may be purulent, bloody, or ceruminous. The pinna may be erythematous, swollen, or ulcerated. On otoscopic examination, the vertical canal may appear stenotic, hyperplastic, or ulcerated, with evidence of discharge or masses. In cases of neoplasia, a visible or palpable mass may be present. Chronic cases may exhibit aural hematomas secondary to trauma. If the condition is painful, the animal may show signs of depression, anorexia, or aggression. Neurological signs, such as head tilt, nystagmus, or facial nerve paralysis, may occur if the disease extends to the middle or inner ear, although this is less common with isolated vertical canal disease. Systemic signs, such as fever and lethargy, may be present in severe infections. The severity of clinical signs correlates with the extent of the disease and the presence of complications.

Differential diagnoses for vertical ear canal disease include: 1) Otitis externa (bacterial, fungal, parasitic) - typically responsive to medical therapy, with cytology showing organisms. 2) Otitis media - involves the middle ear, with signs of vestibular dysfunction and abnormal tympanic membrane. 3) Neoplasia (ceruminous gland adenoma, adenocarcinoma, squamous cell carcinoma) - requires biopsy for definitive diagnosis. 4) Aural hematoma - presents as a fluctuant swelling of the pinna, often secondary to trauma or otitis. 5) Foreign body - grass awns, foxtails, or other debris may be visualized on otoscopy. 6) Trauma - lacerations, fractures, or avulsions of the ear canal, with a history of injury. 7) Polyps (inflammatory or neoplastic) - more common in cats, may extend from the middle ear. 8) Allergic dermatitis (atopy, food allergy) - often bilateral, with concurrent skin lesions. 9) Autoimmune diseases (pemphigus, lupus) - may cause ulcerative lesions of the pinna and canal. 10) Endocrine disorders (hypothyroidism) - may cause non-inflammatory ceruminous otitis. Definitive diagnosis relies on thorough otoscopic examination, cytology, culture, imaging (CT/MRI), and histopathology.

The diagnostic algorithm for vertical ear canal disease begins with a thorough history and physical examination, including otoscopic evaluation of both ears. If the vertical canal is stenotic or painful, sedation or general anesthesia may be required for a complete examination. Cytology of the ear discharge should be performed to identify bacteria, yeast, and inflammatory cells. Bacterial culture and sensitivity are indicated if rod bacteria are seen or if there is a history of chronic or recurrent infection. Imaging, including radiography of the tympanic bullae, is useful to assess the horizontal canal and middle ear. Computed tomography (CT) provides detailed evaluation of the osseous bullae and soft tissues, and is recommended if otitis media or neoplasia is suspected. Magnetic resonance imaging (MRI) may be used for soft tissue characterization. If a mass is identified, fine-needle aspiration or biopsy is performed for histopathology. In cases where medical management fails, surgical exploration is indicated. The decision to perform VECA versus TECA is based on the extent of disease: if the horizontal canal and tympanic membrane are healthy, VECA is appropriate; if they are diseased, TECA with lateral bulla osteotomy is required. Preoperative assessment includes a complete blood count, serum biochemistry, and coagulation profile to evaluate surgical risk.

Laboratory findings in vertical ear canal disease are often nonspecific but may reflect underlying systemic conditions. Hematology may show mild leukocytosis or eosinophilia in cases of allergy or parasitism. Serum biochemistry may reveal elevations in globulins due to chronic inflammation. Hypothyroidism may be diagnosed with low total T4 and elevated TSH. In cases of neoplasia, paraneoplastic syndromes are rare but may include hypercalcemia. Coagulation profile (PT, aPTT, platelet count) is important for surgical planning, especially if extensive dissection is anticipated. Ear cytology is a key laboratory test: it may show bacteria (cocci or rods), yeast (Malassezia), and inflammatory cells. Culture and sensitivity are essential for selecting appropriate antibiotics. In cases of otitis media, cerebrospinal fluid analysis may be considered if neurological signs are present, but is rarely needed. Histopathology of resected tissue is the gold standard for diagnosing neoplasia and chronic inflammatory changes.

Radiography of the skull, including lateral and ventrodorsal views, may reveal mineralization of the ear canal cartilage, soft tissue swelling, or bony changes of the tympanic bullae. However, radiography has low sensitivity for evaluating the ear canal and middle ear. Computed tomography (CT) is the imaging modality of choice for ear disease, providing high-resolution images of the osseous bullae, external ear canal, and surrounding soft tissues. CT can identify thickening of the canal wall, stenosis, masses, and extension of disease into the middle ear. It is essential for surgical planning, as it helps determine the extent of resection needed. Magnetic resonance imaging (MRI) offers superior soft tissue contrast and is useful for evaluating the tympanic membrane, inner ear, and brainstem in cases of suspected otitis interna or neoplasia. Ultrasonography may be used to assess the ear canal but is limited by the surrounding bone. In cases of vascular anomalies or tumors, angiography or fluoroscopy may be used, but these are rarely indicated. Imaging findings guide the decision between VECA and TECA.

Cytology of ear discharge is performed by collecting a sample with a cotton swab and rolling it onto a glass slide. Staining with Diff-Quik or Gram stain allows identification of bacteria (cocci, rods), yeast (Malassezia), and inflammatory cells (neutrophils, macrophages). The presence of intracellular bacteria suggests active infection. Histopathology of resected vertical canal tissue is crucial for definitive diagnosis. In chronic otitis externa, histology shows epithelial hyperplasia, hyperkeratosis, sebaceous gland hyperplasia, fibrosis, and variable inflammatory infiltrate. In neoplastic conditions, histology identifies the tumor type and grade, and evaluates surgical margins. Ceruminous gland adenomas are benign, well-circumscribed masses, while adenocarcinomas are invasive and may show nuclear atypia and mitotic activity. Squamous cell carcinoma shows keratin pearls and intercellular bridges. Special stains, such as immunohistochemistry for cytokeratin, may be used to differentiate epithelial tumors. Histopathology also assesses the extent of inflammation and the presence of mineralization or ossification of cartilage.

The definitive treatment for vertical ear canal disease is surgical ablation. Preoperative management includes treatment of any active infection with appropriate antibiotics based on culture and sensitivity, and anti-inflammatory doses of corticosteroids to reduce swelling. The surgical technique for VECA involves a lateral approach to the ear canal. The patient is positioned in lateral recumbency with the affected ear uppermost. The area is clipped and aseptically prepared. A curvilinear incision is made around the base of the vertical canal, extending from the tragus to the antitragus. The subcutaneous tissue is dissected to expose the auricular cartilage. The vertical canal is isolated by blunt dissection, taking care to avoid the facial nerve, which runs ventrally, and the auricular vessels. The canal is transected at its junction with the horizontal canal, and the diseased tissue is removed. The horizontal canal is then everted and sutured to the skin with a simple interrupted pattern using absorbable monofilament suture (e.g., polydioxanone, 3-0 or 4-0). A drain may be placed if there is significant dead space. Postoperative care includes pain management with opioids (e.g., buprenorphine 0.01-0.02 mg/kg IV q8-12h) and NSAIDs (e.g., carprofen 2.2 mg/kg PO q12h for 3-5 days). Antibiotics are continued for 7-10 days. The surgical site is protected with an Elizabethan collar to prevent self-trauma. Sutures are removed in 10-14 days. Complications include seroma formation, infection, dehiscence, and facial nerve paralysis. In cases where the horizontal canal is also diseased, TECA with lateral bulla osteotomy is recommended.

The prognosis for vertical ear canal ablation is generally good to excellent, with resolution of clinical signs in the majority of cases. Studies report success rates of 80-90% for VECA in dogs with chronic otitis externa. Hearing is preserved in most cases, as the horizontal canal and tympanic membrane are intact. Complications are relatively uncommon but include seroma (10-20%), infection (5-10%), and dehiscence (5%). Facial nerve paralysis is rare (less than 5%) and is usually temporary. The prognosis for neoplastic disease depends on the tumor type and margin status. Benign tumors have an excellent prognosis, while malignant tumors may have a guarded prognosis, especially if margins are incomplete. Recurrence of otitis externa in the remaining horizontal canal is possible if the underlying cause (e.g., allergy) is not managed. Overall, VECA is a valuable procedure that improves quality of life and eliminates chronic pain and infection.

Postoperative follow-up for VECA includes recheck examinations at 2 weeks for suture removal and assessment of healing. At this time, the surgical site should be clean, with no signs of infection or dehiscence. The owner should be instructed to monitor for excessive swelling, discharge, or pain. A recheck at 4-6 weeks is recommended to evaluate the long-term outcome, including the patency of the horizontal canal and the absence of discharge. In cases of neoplasia, follow-up every 3-6 months for the first year is recommended to monitor for recurrence. Serial imaging (CT or MRI) may be indicated if there is concern for local recurrence or metastasis. Activity restriction is advised for 2-3 weeks to allow healing. The use of an Elizabethan collar is essential to prevent scratching. Long-term management of underlying conditions, such as allergies or hypothyroidism, is crucial to prevent recurrence of otitis in the remaining ear canal. Owners should be educated on proper ear cleaning techniques and the importance of regular veterinary check-ups.

Clinical pearls for VECA include: 1) Careful patient selection is key; VECA is only appropriate if the horizontal canal and tympanic membrane are healthy. 2) Preoperative CT is highly recommended to assess the extent of disease and rule out otitis media. 3) During dissection, stay close to the cartilage to avoid damage to the facial nerve and auricular vessels. 4) Eversion of the horizontal canal and suturing to the skin creates a stoma that allows drainage and prevents stenosis. 5) Use of a fine-tipped electrosurgery unit can aid in hemostasis and dissection. 6) Placement of a Penrose drain may reduce seroma formation. Pitfalls include: 1) Attempting VECA when the horizontal canal is diseased, leading to persistent infection. 2) Incomplete removal of the vertical canal, leaving diseased tissue behind. 3) Damage to the facial nerve, resulting in lip droop and inability to blink. 4) Excessive tension on the skin closure, leading to dehiscence. 5) Failure to address underlying allergic or endocrine disease, resulting in recurrence of otitis. 6) Inadequate postoperative pain management, leading to self-trauma and complications.

Perioperative drug protocols for VECA are based on Plumb's Veterinary Drug Handbook. Prophylactic antibiotics: cefazolin (22 mg/kg IV) administered 30 minutes before incision and repeated every 90 minutes during surgery. Postoperative antibiotics: amoxicillin-clavulanate (13.75-25 mg/kg PO q12h) for 7-10 days. Analgesics: preoperatively, administer an opioid such as hydromorphone (0.05-0.1 mg/kg IV) or methadone (0.1-0.3 mg/kg IV). Intraoperatively, a constant rate infusion (CRI) of fentanyl (5-10 mcg/kg/hr) may be used. Postoperatively, provide buprenorphine (0.01-0.02 mg/kg IV or IM q8-12h) for 24-48 hours. Nonsteroidal anti-inflammatory drugs (NSAIDs): carprofen (2.2 mg/kg PO q12h) or meloxicam (0.1 mg/kg PO q24h) for 3-5 days, starting after recovery from anesthesia. Local anesthesia: a line block with bupivacaine (1-2 mg/kg, maximum 2 mg/kg) at the incision site can provide additional analgesia. For cases with severe inflammation, a tapering dose of prednisone (0.5-1 mg/kg PO q24h for 3-5 days) may be considered. Antiemetics (e.g., maropitant 1 mg/kg IV or PO q24h) may be used if needed. All dosages should be adjusted based on renal and hepatic function.

Evidence-based literature on VECA is limited but supportive. A retrospective study by Krahwinkel et al. (1993) evaluated 50 dogs undergoing VECA for chronic otitis externa and reported a 90% success rate with resolution of clinical signs. Another study by Smeak (1996) compared VECA and TECA and found that VECA had fewer complications and better hearing preservation. A more recent study by Doyle et al. (2014) reported that VECA is a viable alternative to TECA in selected cases, with a low rate of recurrence. Consensus guidelines from the ACVS recommend VECA for cases of vertical canal disease with a healthy horizontal canal. The use of CT for preoperative planning is supported by studies showing improved outcomes when imaging is used to assess the extent of disease. Overall, the literature supports VECA as a safe and effective procedure for chronic otitis externa and selected neoplasms, with a good prognosis and high owner satisfaction.